Shah Gaurav bought RCKT

February 11, 2026 · Form 4 insider transaction

Shah Gaurav bought 870,648 shares of Rocket Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Acquired (buy-side)
Shares
870,648
Price
$0.00
Total value
N/A
RoleOfficer, Director
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateFebruary 11, 2026
Filing dateFebruary 13, 2026
Shares owned after870,648
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

This option represents a right to purchase a total of 870,648 shares of the Issuer's common stock, one-third of which will become fully vested and exercisable on February 11, 2027, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer.

View the original Form 4 on SEC EDGAR